CenExel Two-Site Solution Supports Cyclerion’s CIAS Study with Exploratory EEG Assessments
Cyclerion Therapeutics presented positive topline data today, July 28, 2022, during a webinar on their C6463-103 Phase 1 Schizophrenia study entitled,...
CenExel Acquires Apex Innovative Sciences
CenExel announces the acquisition of Apex Innovative Sciences, parent company of Collaborative Neuroscience Research (CNS) and Hassman Research Institute...
Apex Attending ISCTM 2022
Will you be in Boston for ISCTM? September 8 and 9, Apex Innovative Sciences will be available for meetings to discuss how we can support your clinical...
Will You be at BIO 2022?
The 2022 BIO International Convention in San Diego is coming up next week! Apex Innovative Sciences' Vice President of Business Development, Guy Sheets,...
Apex Attending the American Diabetes Association’s 82nd Scientific Sessions
Are you going to the American Diabetes Association 82nd Scientific Sessions (#ADA2022) in New Orleans, June 3rd-6th, 2022? Schedule time to meet with Apex...
Apex Attending BIO 2022
Are you going to the 2022 BIO International Convention June 13-16 in San Diego, CA? Apex Innovative Science's Senior Director of Business Development,...
Drs. Ereshefsky and English to Participate in ASCP Panel Discussion
The 2022 ASCP Annual Meeting begins in just TWO weeks! If you'll be in Scottsdale, please join us, along with a panel of speakers from academia and pharm,...
Apex Attending Psychedelic Therapeutics and Drug Development Conference
Are you attending the 2nd Annual Psychedelic Therapeutics and Drug Development Conference in Washington, DC on May 23-24, 2022? Apex Innovative Sciences'...
Dr. Elan Cohen’s Poster Presentation at ASCP 2022
Elan Cohen, Ph.D., Principal Investigator at HRI, will be presenting "Enhancing Participant Retention: Lessons Gained From Attention-Deficit/ Hyperactivity...
Are You Attending ASCP? Let’s Meet
ASCP 2022 starts in just twenty-nine days! Have you scheduled time with Apex Innovative Sciences to talk about your upcoming clinical trials? Our Senior...